Lee Sang-Min, Shin Jong-Seok, Choi Hong-Jo, Park Ki-Jae, Roh Young-Hoon, Kwon Hyuk-Chan, Roh Mee-Sook, Lee Hyung-Sik, Kim Choongrak
Department of Surgery, Dong-A University Medical Center, Busan, Korea.
J Korean Surg Soc. 2011 Apr;80(4):260-6. doi: 10.4174/jkss.2011.80.4.260. Epub 2011 Apr 12.
The aim of this study was to evaluate the prognostic significance of the ratio between metastatic and examined lymph nodes (LNs) in patients with stage III rectal cancer.
A review was made of 175 (male, 98) patients with stage III rectal cancer of R0 resection. LN disease was stratified both by the American Joint Committee on Cancer/International Union Against Cancer nodal classification (pN) and by quartiles of the lymph node ratio (LNR). Disease-free survivals (DFS) were made using Kaplan-Meier curves and assessed by the log rank test and multivariate analysis was performed using the Cox proportional hazards model.
Patients ranged in age from 29 to 83 (median, 60) years with median follow-up of 47 months (range, 13 to 181 months). months. There was a significant correlation between the number of metastatic LNs and the LNR (r = 0.8681, P < 0.0001). Cut-off points of LNR quartiles best to separate patients with regard to 5-year DFS were between quartile 2 and 3, and between 3 and 4 (LNR1, 2, and 3); the 5-year DFS according to such stratification was 89.6%, 55.8%, and 18.2% in LNR1, 2, and 3, respectively (P < 0.0001). Cox model identified the LNR as the most significant independent prognostic covariate; LNR2 showed 3.6 times (95% confidence interval [CI], 1.682 to 7.584; P = 0.0009) and LNR3, 18.7 times (95% CI, 6.872 to 50.664; P < 0.0001) more risky than LNR1.
This study suggests that ratio-based LN staging, which reflects the number of LNs examined and the quality of LN dissection, is a simple and reliable system for prognostic LN stratification in patients with stage III rectal cancer.
本研究旨在评估Ⅲ期直肠癌患者转移淋巴结与检查淋巴结数量之比的预后意义。
回顾性分析175例(男性98例)行R0切除的Ⅲ期直肠癌患者。淋巴结疾病按美国癌症联合委员会/国际抗癌联盟淋巴结分类(pN)以及淋巴结比率(LNR)四分位数进行分层。采用Kaplan-Meier曲线计算无病生存期(DFS),并通过对数秩检验进行评估,使用Cox比例风险模型进行多因素分析。
患者年龄范围为29至83岁(中位年龄60岁),中位随访时间为47个月(范围13至181个月)。转移淋巴结数量与LNR之间存在显著相关性(r = 0.8681,P < 0.0001)。就5年DFS而言,LNR四分位数的最佳分界点在第2和第3四分位数之间以及第3和第4四分位数之间(LNR1、2和3);根据这种分层,LNR1、2和3组的5年DFS分别为89.6%、55.8%和18.2%(P < 0.0001)。Cox模型确定LNR是最显著的独立预后协变量;LNR2组的风险是LNR1组的3.6倍(95%置信区间[CI],1.682至7.584;P = 0.0009),LNR3组的风险是LNR1组的18.7倍(95%CI,6.872至50.664;P < 0.0001)。
本研究表明,基于比率的淋巴结分期反映了检查的淋巴结数量和淋巴结清扫质量,是Ⅲ期直肠癌患者预后淋巴结分层的一种简单可靠的系统。